It has been suggested that it provides the relatively water-impermeable barrier which must be present in the ascending limb of the loop of Henle for generation of the essential hypertonicity of the renal medulla (Sikri et al., 1979; Hoyer & Seiler, 1979) .
There is evidence that the glycoprotein is implicated in some pathological states. Cellmediated immunity to the glycoprotein is reported to occur in many patients with renal tubular acidosis accompanying autoimmune liver disease (Tsantoulos et al., 1974) , and the lymphocytes from many of these patients have been shown to be cytotoxic for a line of cultured kidney cells (Cochrane et al., 1976) , possibly because the latter are producing the glycoprotein or an immunologically cross-reactive substance (Bloomfield et al., 1977) . There are increased levels of autoantibodies to Tamm-Horsfall glycoprotein in the sera of those Abbreviations used: NaCNS, sodium thiocyanate; SDS, sodium dodecyl sulphate.
with upper, but not lower, urinary tract infection (Larsson et al., 1978; Fasth et al., 1979) and in some patients with urinary tract obstruction accompanied by infection (Marier et al., 1978) . An understanding of these phenomena requires recognition of the antigen(s) involved, as well as of crossreactive substances.
The results of applying a radioimmunoassay procedure to normal human sera were interpreted as evidence for the presence of a substance, in amounts of 0.05-0.18 mg/I, which reacted similarly to the Tamm-Horsfall glycoprotein (Avis, 1977) . Dawnay et al. (1980) reported that non-aggregated Tamm- Horsfall glycoprotein is present in normal human serum in amounts of 0.07-0.54 mg/l, although the identity of the material was not unequivocally established.
The present results show that Tamm-Horsfall glycoprotein does not occur in normal human serum, although there are proteins which are immunologically cross-reactive with it and which have been isolated in amounts of about 20 mg/l. Materials 
Isolation of Tamm-Horsfall glycoprotein
The glycoprotein was isolated from pooled, adult urine by procedures described earlier (Tamm & Horsfall, 1952) and freeze-dried.
Raising ofantiserum
Antiserum to freeze-dried Tamm-Horsfall glycoprotein was raised in New Zealand white rabbits by multiple intradermal injections (5 x 0.1 ml), every month, of an emulsion containing equal volumes of the glycoprotein (0.5 mg/ml of water) and complete Freund's adjuvant. Blood, taken from the ear veins of the immunized rabbits after a total of at least four sets of injections, was allowed to clot and the serum was collected. It was stored in small portions at -200C.
Isolation ofIgGfrom antiserum andfrom the serum ofnon-immunized rabbits IgG was obtained by chromatographing dialysed (against starting buffer) rabbit antiserum (5 ml), or serum from non-immunized rabbits, on a column (2cm x 12cm) of DEAE-cellulose (DE52 Whatman) at pH6.4 in 0.0175M-phosphate buffer (Sober & Peterson, 1958) . The rate of elution was 12 ml/h and 15 ml fractions were collected. The peak fractions containing IgG were combined and dialysed against water before freeze-drying. Yields were about 27mg from the immunized rabbit and 21 mg from the non-immunized rabbit.
Preparation of IgG-Sepharose 4B for affinity chromatography IgG was coupled to Sepharose 4B by a modification of the procedure of Cuatrecasas (1970) . Amounts of CNBr-activated Sepharose 4B (5 g) were swollen for 15 min in a sintered-glass funnel with 1 mM-HCI (200ml/g of Sepharose 4B).
Anti-(Tamm-Horsfall glycoprotein)IgG (25 mg) was dissolved in 50 ml of a solution of 0.1 MNaHCO3 containing 0.5 M-NaCl in a plastic container. To the solution was added a 5 g amount of the swollen Sepharose 4B gel, and the mixture was allowed to react on a roller for 2h at 210C. The mixture was washed on a sintered glass funnel with 0.1 M-NaHCO3. containing 0.5M-NaCl, and A280 measurements of the collected washings indicated ding of 70-80% of the IgG. The IgG-Sepharose 4B preparation was mixed with 1 M-ethanolamine/HCl (pH 8, 30 ml) for 2 h at 210C on the roller. The supernatant was decanted and the gel was washed successively, with three washing cycles in all, with 0.1 M7sodium acetate buffer, pH 4, containing 1 M-NaCl, and 0.1 M-sodium borate buffer, pH 8.5, containing 1 M-NaCl. The gel was washed overnight by gentle stirring with chloride/phosphate buffer, pH 7.0 (1.7mM-Na2HPO4, 0.52mM-KH2PO4, 44mM-NaCI) which also contained 0.02% NaN3. When necessary the gel was stored at 40C in this azide-containing buffer.
Affinity chromatography
Samples of blood were collected from normal individuals on the day when the experiments were begun. They were allowed to clot for 2h at 210C and the serum was separated. The samples of fresh serum (100-200ml) were dialysed overnight against the chloride/phosphate buffer and then an equal volume of the buffer was added to the serum.
The diluted serum was divided into 30 ml volumes, and each of these was mixed successively for 40min at 21°C on the roller with a 5g portion of the IgG-Sepharose 4B preparation. Before each successive addition, the beads were allowed to settle and the supernatant was removed by aspiration. The mixing of the last fraction was usually done overnight.
The beads were washed in a sintered-glass funnel with chloride/phosphate buffer and then poured into a column (5 cm x 2 cm) and eluted with the same buffer at a rate of 50-100ml/h until after the A280 value of the eluate had reached zero (-500ml of eluting buffer was usually used). The column was operated at 21 IC. It was eluted, either with 1% SDS in chloride/phosphate buffer or with 3.5M-NaCNS solution, at a rate of 12ml/h. Constant fractions (2-6 ml in different experiments) were collected. Those containing 3.5 M-NaCNS were dialysed exhaustively against water. The absorbances of the fractions at 280nm were determined, and those fractions containing protein were subjected to polyacrylamide-gel electrophoresis in presence of SDS.
The IgG-Sepharose 4B preparations were reutilized after washing with large volumes (lOOOml) of phosphate/chloride buffer, and stored in this same buffer with 0.02% sodium azide, at 40C.
Polyacrylamide-gel electrophoresis in the presence of
SDS
This was done by a modification of the procedure of Marshall & Zamecnik (1969) . Gels of 7.5% were used, and electrophoresis (0.5-1 mA per gel) was performed at room temperature with 0.1% SDS in Serum proteins, cross-reactive with Tamm-Horsfall glycoprotein the running buffer (Khalkhali & Marshall, 1976) . The samples had been kept at 400C in the presence of 1% SDS for at least 1 h before electrophoresis.
Crossed immunoelectrophoresis
A modification of the procedure of Laurell (1965) was used, with 1% agarose in sodium barbital/HCl buffer (0.06 M in barbital), pH 8.6. Freeze-dried Tamm-Horsfall glycoprotein (lO,ul of a solution, 0.1 mg/ml, in 0.3% SDS) was examined.
Electrophoresis in the first dimension was carried out in gels 9 cm x 2 cm x 0.15 cm at 20 V/cm for 1.5h, and that in the second dimension for 24h at 5 V/cm into a 9cm x 7cm x 0.15cm gel containing 0.5% rabbit anti-(human Tamm-Horsfall glycoprotein) serum.
The gel was then washed in 154 mM-NaCI for 24 h and stained with Coomassie Brilliant Blue R250 (0.25% in 1.3 M-acetic acid) for 10min at 21 IC. The gels were destained in acetic acid/methanol/water mixture (38 ml of acetic acid plus 500 ml of methanol made up to a volume of 1 litre with water).
lodination of Tamm-Horsfall glycoprotein Tamm-Horsfall glycoprotein was allowed to dissolve in water (1 mg/ml) at 370C overnight. Portions of this solution were used both for iodination and as the standard in the radioimmunoassay. Nal'25I solutions (5,ul containing 0.5 mCi) was added to 100,ul of the glycoprotein solution immediately after addition of 50,ul of phosphate buffer, pH7.4 (19.6ml of 0.5M-KH2PO4 plus 80.4 ml of 0.5 M-Na2HPO4). Chloramine-T solution (SO,1; 4mg/mi) in Dulbecco A buffer (Dulbecco & Vogt, 1954) was added, the tube was stoppered and the solution was mixed. The reaction was stopped after 30s by addition of 0.2ml of sodium metabisulphite solution (4.8mg/ml in the same buffer). KI (0.4 ml; 20 mg/ml in buffer) was added, followed by 0.2ml of bovine serum albumin solution (30mg/ ml in buffer). The radiolabelled Tamm-Horsfall glycoprotein was separated on a Sephacryl S-200 column (30cm x 1.5 cm) equilibrated with Dulbecco A buffer containing 0.02% sodium azide (flow rate 40ml/h; fraction size 3 ml). The labelled protein fraction was diluted 10-fold in buffer containing bovine serum albumin (2 g/l), and sodium azide (0.02%), and the solution was stored in portions at -200C for no longer than 4 days. The specific radioactivity was 2.9,uCi/,ug (S.D. + 0.7; n = 8).
Dilutions for assay were prepared and these contained 100 000 c.p.m. per 0.3 ml.
Radioimmunoassay
This was carried out by a modification of the method of Grant & Neuberger (1973) .
The standard Tamm-Horsfall glycoprotein solution (1 mg/ml) was serially diluted with buffer containing 0.0011% SDS to give concentrations of 25000, 12500, 6250, 3125, 1560, 781, 390, 195, 98 and 49ng/ml. The material isolated from serum was serially diluted in a similar way at concentrations ranging from 100000 to 195mg/ml. All solutions were incubated overnight at 37°C.
Diluted rabbit antiserum (1: 2000 in 0.1 M-Tris/ HC1 buffer, pH 9.5; 0.5 ml) was incubated in polystyrene tubes (40mmx 11mm; 1.5h; 210C), and the tubes were then washed with two 0.6ml volumes of Dulbecco A buffer. Bovine serum albumin solution (5g/l in Dulbecco A buffer) was incubated in the tubes (0.5 h; 21 0C) and removed by aspiration. Tamm-Horsfall glycoprotein or serum protein solution (0.25 ml) was then added, followed by 0.3 ml of the radiolabelled solution (100000c.p.m.). The stoppered tubes were kept at 370C for 16h and the solutions were aspirated to remove unbound antigen. After washing the tubes twice (2 x 0.7 ml of water), they were assessed for radioactivity. Non-specific binding was assessed by omission of antibody. All values were less than 1% of the total radioactivity used. All assays were done in duplicate. (Fig. 1) . A dilution of antiserum of 1: 2000 was used to coat the tubes in the radioimmunoassay.
Affinity chromatography of 200ml of dialysed human serum, in a system in which Sepharose 4B linked to IgG raised in rabbits against human TammHorsfall glycoprotein was used as the affinity material, led to binding of only a few mg of the greater than lOg of protein in the original serum. After thorough washing of the adsorbent, with the phosphate/chloride buffer, until after A280 of the Serum proteins, cross-reactive with Tamm-Horsfall glycoprotein eluate was zero, the column was prepared and was eluted with 3.5 M-NaCNS solution (pH 6.8 ). An amount of 4.02 mg of protein was found, on the assumption that a concentration of 1 mg/ml gives an absorbance of unity. A further smaller amount of protein (0.78 mg) was eluted with 1% SDS (Fig. 2a) . The total amount recovered was 24 mg/l of serum. The material in zone A (Fig. 2a) revealed two bands upon polyacrylamide-gel electrophoresis in the presence of SDS (Fig. 3a) . The mobility of the faster one (F) was greater than that of Tamm-HIorsfall glycoprotein. The mobility of the second band (S) was less than that of the latter but greater than that of sheep IgG. Material in zone B (Fig. 2a) was shown to have the same mobility as that in band F (Fig. 3b) .
In a control experiment 130ml of human serum was subjected to affinity chromatography with material made from IgG isolated from the serum of ,'-' rabbits which had not been immunized. The column was eluted successively with the chloride/phosphate buffer (to elute the unadsorbed serum protein), 3.5 M-NaCNS, chloride/phosphate buffer and 1% SDS. Negligible amounts of protein were found in the dissociating eluants (Fig. 2a) .
Tamm-Horsfall glycoprotein exhibits different behaviour from proteins S and F upon affinity chromatography. The glycoprotein (2mg) dissolved in 100ml of buffer was subjected to chromatography in the manner used for serum. It could not be eluted from the column by 3.5 M-NaCNS, but a recovery of the order of 70% was achieved by the use of 1% SDS (Fig. 2b) . It is relevant to mention that Tamm-Horsfall glycoprotein is largely present in a polymeric form in solution in 3.5M-NaCNS, because it was found to be eluted from a Sephacryl S-200 column in this solvent with a VC/VO value of 1.05. On the other hand it exists in its subunit form in 1% SDS solutions (Fletcher et al., 1970 (Fig. 2a) (Fig. 2c) ; (viii) 15,pg of serum protein from zone D (Fig. 2c) . The marker dye, incompletely destained, is seen near the bottom of the gels. Vol. 194 565 (vii} (viii) Elution of serum protein which bound to the affinity material was also effected directly with SDS. Interaction of 150ml of serum with anti-(TammHorsfall)-IgG-Sepharose 4B was followed by elution with chloride/phosphate buffer and then by 1% SDS. A total amount of protein of 2.9mg was eluted by the detergent (Fig. 2c) , equivalent to 19mg/l of serum. Polyacrylamide-gel electrophoresis of the peak fraction (zone C) showed the presence of proteins F and S (Fig. 3c) . In addition, in one of the later fractions (zone D), there was a further band clearly seen (F'). The mobilities relative to Bromophenol Blue were for cytochrome c (0.95), hen's egg albumin (0.56), human serum albumin (0.45), Tamm-Horsfall glycoprotein (0.31), sheep IgG (0.08), protein F' (0.41), protein F (0.37) and protein S (0.14). Apparent mol.wts. may be calculated as 74000, 84 000 and about 125 000 for F', F and S respectively, bearing in mind, that in this system of electrophoresis, Tamm-Horsfall glycoprotein behaves as a protein with an apparent mol.wt. of 105 000 (Fletcher et al., 1970) .
A similar experiment was done on a mixture of The concentrations of protein in the two cases are shown on the abscissa as ng/ml. The radiolabel for both curves was '25l-labelled Tamm-Horsfall glycoprotein and the assays for the urinary and serum derived proteins were done in the same experiment.
175 ml of dialysed serum to which had been added 1.4 mg of Tamm-Horsfall glycoprotein before interaction with the affinity gel. Elution with 1% SDS, subsequent to elution of the bulk of the protein with the chloride/phosphate buffer, yielded an elution pattern like that shown in Fig. 2(c) . A total of 3.9mg of protein was found. Polyacrylamide-gel electrophoresis in the presence of SDS of the peak fraction revealed that protein F and Tamm-Horsfall glycoprotein were present (Fig. 3d) , as distinct materials. Material (zone A, Fig. 2a ) isolated by affinity chromatography with the use of 3.5 M-NaCNS was subjected to radioimmunoassay after exhaustive dialysis against water followed by Dulbecco A buffer containing 0.0011% SDS. The substance isolated from serum was found to have a much lower affinity for the antibody than did Tamm-Horsfall glycoprotein (Fig. 4) . About 60-70 times as much of the substances in serum are required as of freezedried Tamm-Horsfall glycoprotein to compete with a given amount of the radiolabelled form of the latter.
Urinary Tamm-Horsfall glycoprotein, which had been subjected to gel filtration in the presence of urea, gave two protein peaks ( Pooled fractions I and 1I were individually dialysed against water and freeze-dried. Amounts of 5.5 and 25 mg respectively were found (85% recovery). The elution volume for bovine serum albumin was 222 ml. . . , , . (II)] with electrophoretic mobilities in the presence of SDS unaltered from that of the original material (Fig. 6) . The mobility was different from those of proteins S and F.
Radioimmunoassay of fractions I, II and of the glycoprotein itself were carried out by using the same preparation of radiolabelled glycoprotein. The results showed (Fig. 7) that about three times as much of the aggregated form of the urea-treated glycoprotein (I, Fig. 5 ) as qf the disaggregated material (II) was required to compete with a given amount of the radiolabelled glycoprotein.
Discussion
There are present, in normal human serum, three proteins which we have called S, F and F', which will bind to IgG isolated from the serum of rabbits immunized with human urinary Tamm-Horsfall glycoprotein. The proteins have apparent molecular weights, as assessed by disc-gel electrophoresis in the presence of SDS, of 125 000, 84000 and 74000 respectively. The mobility of each of these differs from that of Tamm-Horsfall glycoprotein, the presence of which could not be demonstrated in normal serum.
In addition, the proteins S and F differ from Tamm-Horsfall glycoprotein in that their complexes with Sepharose 4B-linked antibody can be dissociated in 3.5 M-NaCNS. This reagent, in which Tamm-Horsfall glycoprotein exists in an aggregated form, does not dissociate the urinary glycoprotein-antibody complex.
The cross-reacting serum proteins compete with radiolabelled Tamm-Horsfall glycoprotein in the immunoassay, although they are bound less avidly than is the latter. About 60-70 times as much of the serum proteins are required as of Tamm-Horsfall glycoprotein to compete with a given amount of I251-labelled urinary glycoprotein.
The cross-reacting serum proteins were isolated in amounts of 19-24 mg/l of serum, and it is likely that this represents a substantial proportion of that originally present, in view of the recovery found in the present work (70%) for Tamm-Horsfall glycoprotein itself (see also Dunstan et al., 1974 It was reported by Dawnay et al. (1980) that gel filtration of Tamm-Horsfall glycoprotein in the presence of urea, under the conditions used in the present experiments (Fig. 5) , yielded a product, which was more mobile upon polyacrylamide-gel electrophoresis in the presence of SDS than was the original glycoprotein. The precise results on which this claim was made were not given, but in our experience this report is erroneous. The electrophoretic mobilities of both fractions from the Bio-Gel column (Fig. 5) and of Tamm-Horsfall glycoprotein itself were identical (Fig. 6) and their immunoreactivities were similar (Fig. 7) . Dawnay et al. (1980) deduced from their reported findings that normal human serum contains a monomeric form of urinary Tamm-Horsfall glycoprotein. Our results would suggest that this is not so.
The present findings raise many questions. The serum proteins require characterization in order to understand the basis of the immunological crossreactivity with Tamm-Horsfall glycoprotein. The identity of the substance associated with the hepatocyte plasma membrane, which interacts weakly with antibody raised against Tamm-Horsfall glycoprotein (Tsantoulos et al., 1974) , requires elucidation and the results might help to explain why a relatively large number of patients with autoimmune hepatic disease (32% in one study ; Golding et al., 1973) have an associated renal tubular acidosis. The nature of the substance, cross-reactive with Tamm-Horsfall glycoprotein and produced by a line of cultured kidney cells (Bloomfield et al., 1977) , is presently uncertain.
The antigen involved in the formation of antibodies, which interact with Tamm-Horsfall glycoprotein in vitro in those with acute pyelonephritis (Fasth et al., 1979) , or with cystic fibrosis (Fasth & Kollberg, 1980) , is unknown. Whether the antibodies produced react also with the serum protein is problematical. Clarification of the nature of the antibodies, demonstrated by indirect immunofluorescence, reactive with the epithelium of the cortical ascending limb of the loop of Henle and of the distal convoluted tubule and present in the sera of patients with disorders presumed to be of immune aetiology (Pasternak & Linder, 1970; Ford, 1973; Chanarin et al., 1974) is needed. Further investigation of the nature of the factor produced by cultured normal fibroblasts, that inhibits induction, by Tamm-Horsfall glycoprotein, of alkaline phosphatase in fibroblasts derived from cystic fibrosis patients (Carey & Hosli, 1979) , might yield interesting information in the light of our findings.
